Pharmaceutical protections in U.S. trade deals — what do Americans get in return?

New England Journal of Medicine

1 May 2019 - U.S. trade deals increasingly include terms affecting the approval process and availability of medicines. 

Why did the United States begin pushing for expanding pharmaceutical protections in trade agreements, and have Americans gotten what they were promised in return?

Read New England Journal of Medicine Perspective 

Michael Wonder

Posted by:

Michael Wonder